|Bid||0.00 x 900|
|Ask||161.91 x 1000|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||0.54|
|PE Ratio (TTM)||26.52|
|Earnings Date||Aug 1, 2019|
|Forward Dividend & Yield||4.24 (2.66%)|
|1y Target Est||147.36|
Commenting on Clorox Co. during the Lightning Round of Mad Money Tuesday night, Jim Cramer said: "The last quarter wasn't that good but the stock is still up. The technical indicators look like they can support an upside breakout in the near future. The daily On-Balance-Volume (OBV) line has been rising the past twelve months and it has just made a new high for the move up to foreshadow a potential breakout.
In the news release, Capricorn Business Acquisitions Announces Letter of Intent with Tikun Olam Skincare, issued 15-Jul-2019 by Capricorn Business Acquisitions Inc. over CNW, we are advised by the company that the biographical information for Gerald Goldberg has been amended. TORONTO , July 15, 2019 /CNW/ - Capricorn Business Acquisitions Inc. (CAK-H.V) ("Capricorn" or the "Company"), a capital pool company, is pleased to announce that it has entered into a letter of intent dated July 1, 2019 ("LOI") with Delaware -based Tikkun Pharma, Inc., d/b/a Tikun Olam Skincare ("TO Skincare") that outlines the general terms and conditions pursuant to which Capricorn and TO Skincare would be willing to complete a transaction that will result in a reverse take-over of Capricorn by the shareholders of TO Skincare, and which is intended to constitute the "Qualifying Transaction" of Capricorn (the "Qualifying Transaction") pursuant to the policies of the TSX Venture Exchange (the "Exchange").
TORONTO , July 15, 2019 /CNW/ - Capricorn Business Acquisitions Inc. (CAK-H.V) ("Capricorn" or the "Company"), a capital pool company, is pleased to announce that it has entered into a letter of intent dated July 1, 2019 ("LOI") with Delaware -based Tikkun Pharma, Inc., d/b/a Tikun Olam Skincare ("TO Skincare") that outlines the general terms and conditions pursuant to which Capricorn and TO Skincare would be willing to complete a transaction that will result in a reverse take-over of Capricorn by the shareholders of TO Skincare, and which is intended to constitute the "Qualifying Transaction" of Capricorn (the "Qualifying Transaction") pursuant to the policies of the TSX Venture Exchange (the "Exchange").
The staples sector has gained 19.9% this year, edging out most other sectors. The stocks appear to be rising almost entirely due to multiple expansion, rather than forecast earnings growth.
OAKLAND, Calif. , July 9, 2019 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that it will host a live audio webcast of a discussion with the investment community about its fourth-quarter ...
Clorox Co NYSE:CLXView full report here! Summary * Perception of the company's creditworthiness is neutral * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for CLX with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $9.02 billion over the last one-month into ETFs that hold CLX are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. CLX credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll apply a basic...
Clorox (CLX) expects gross margin to be flat in fiscal 2019 as gains from higher prices and cost-savings efforts are likely to be offset by higher costs and adverse currency rates.
Shares of most US household and personal care manufacturers generated double-digit returns in the first half. What does the future hold?
When we talk Dividend Aristocrats and Dividend Kings, it should come as little surprise the Kings and their more than 50 years of increasing dividends earns the same as a lot in the Dividend Aristocrats, given they easily satisfy the criteria that is increasing their dividends for at least 25 years. This led me to suggest investors through the Kings for companies that have inelastic and defensible business models. Now let's do the same for the Dividend Aristocrats.
Procter & Gamble (PG) emphasizes on improving its product portfolio through strategic initiatives. Also, the company is on track with its cost-saving plans.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Clorox Company (The) and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
In 2014 Benno Dorer was appointed CEO of The Clorox Company (NYSE:CLX). This analysis aims first to contrast CEO...
DURHAM, N.C., June 11, 2019 /PRNewswire/ -- Burt's Bees, a leading provider of personal care products committed to natural skin care solutions, today announced research supporting new findings related to the skin's composition and the role of nature-based regimens to protect the skin against common environmental stressors. The studies will be presented at the 24th World Congress of Dermatology (WCD) Meeting in Milan, Italy, June 10-15, 2019.
Computers and electronic devices in healthcare facilities are commonly contaminated with pathogenic microorganisms and regular cleaning and disinfection is needed to keep them from becoming a vehicle for pathogen transmission, but not all equipment is designed to support daily disinfection.
Every year since 2007, the San Francisco Business Times has picked a selection of successful, influential, seasoned business leaders to be recognized as the Bay Area's Most Admired CEOs. The leaders chosen for this honor are selected after months of research and discussion between editors and reporters. Another critical component, however, is the flood of nominations from readers and businesses.
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
As the markets get ready to finish a volatile month, I'd like to discuss the outlook of Procter & Gamble (NYSE:PG), the consumer-goods titan, whose shareholders have had a great year. Over the past 12 months, PG stock is up over 40%.Source: Mike Mozart via Flickr (Modified)Although I would not bet against Procter & Gamble stock in the long-term, I do not find PG stock a compelling buy at its current prices. I expect PG to undergo volatility and possibly weakness in June. Despite the many catalysts that make the shares an important part of a diversified portfolio, the company also faces several short-term risks. Here are the most important things that investors should know about Procter & Gamble stock. * 7 Stocks to Sell Amid an Escalating Trade War Procter & Gamble Has Strong BrandsMany consumer-staples companies have famous brands and robust fundamentals. I'view PG as one of the best consumer-staple names. Founded in 1837, the company is one of the largest manufacturers, distributors, and advertisers of consumer goods globally.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe company has five main segments: * Beauty, * Grooming, * Health Care, * Fabric & Home Care, * Baby, Feminine & Family Care.With its extensive product portfolio, it covers all the basic needs of consumers. On a given day, the average U.S. (and global) household is likely to use many of its brands, including Tide, Bounty, Downy, Pampers, Always, Charmin, Swiffer, Head & Shoulders, Crest, and Gilette.The strength of Procter & Gamble's brands is helping it achieve broad geographic reach and the benefits of large size in this competitive industry. PG Stock Benefits From Robust EarningsPG's fiscal third-quarter results, announced on Apr. 23 ,showed that its sales growth sped up, as its organic sales increased 5%. Chief Financial Officer Jon Moeller highlighted the quarter as the "third quarter in a row of very strong volume, sales, consumption and market share growth being driven by a strategy of superiority."Global annual revenue is over $66 billion and almost two dozen of its brands have annual sales of over $1 billion. Because these products have high margins, PG's return on capital employed (ROCE), a profitability ratio measuring how efficiently a company can generate profits, has been about 16%, which is viewed as healthy.The company has achieved those numbers through both organic growth and acquisitions. For example, the power of its brands enables Procter & Gamble to raise its prices without sacrificing a great deal of sales volume.Furthermore, over the past three years, Procter & Gamble has completed seven acquisitions. For example, in Dec. 2018, it finalized a $4.2 billion deal to purchase Germany-based Merck KGaA's Consumer Health business. PG said that the deal would help it expand its portfolio of consumer-healthcare products. The acquisition has increased PG's exposure to Asian and Latin American markets.Finally, Procter & Gamble's AA credit rating is possibly one of the best testaments of the company's fundamental strength. Procter & Gamble Stock Creates Shareholder ValueAnalysts have highlighted Procter & Gamble's improved margins, helped by cost-cutting across the company. Over the past few years, management has reshaped the company's portfolio to better serve changing consumer trends and spending habits.Dividends should play an important part in long-term investments. As a dividend aristocrat, Procter & Gamble stock is a favorite among income investors.PG's dividend yield is almost 2.9%. Its robust free cash flow will probably enable it to further increase its dividends in coming years. The company has raised its dividend every year since 1957. Over the past decade, PG's dividend has jumped over 60%. PG Stock May Not Be Immune to the U.S.-China Trade WarsAlthough it may not be one of the first stocks most investors think of when assessing the potential impact of the U.S.-China trade wars, Procter & Gamble stock is likely to be adversely affected by increased tariffs. In 2018, PG's management reported that tariff increases would raise the cost of making many of its products.PG relies on China for many parts and materials, such as pipes, tanks, and containers, that are used to manufacture and package its brands.As tariffs rise, PG would either have to increase its prices or absorb the costs. Increasing prices could hurt its sales, while absorbing higher costs would undermine its profitability. Either way, there would likely be downward pressure on PG stock.In April, even before trade-war tensions began intensifying, PG CEO David Taylor stressed that the company faced "a challenging competitive and macroeconomic environment." The rhetoric on tariffs won't ease the headwinds that Taylor described or the pressure they put on PG stock price. Is the Valuation of PG Stock Becoming Stretched?Wall Street has been voicing concerns about the rich valuation of PG stock. InvestorPlace columnist Luke Lango recently analyzed why investors may want to pay close attention to various metrics which indicate that the valuation of Procter & Gamble stock has become stretched.Furthermore rising commodity costs have been impacting the entire consumer-staples sector in the past few months. For example, prices for inputs like plastic, paper, and oil have been rising. Indeed in Oct. 2018, PG blamed rising costs for price increases it levied on many of its brands.Therefore, the owners of PG stock may want to assess the company's sales volumes when it reports its earnings in late July and October, in order to see if they are being adversely affected by the price hikes.If PG's volumes stay flat or fall, then more analysts may begin to find the current valuation levels of PG stock rather high, resulting in downgrades of PG stock. In 2018, a number of analysts downgraded Procter & Gamble stock due to rising commodity costs and price pressures that affected every segment of the company. Should Investors Buy PG Stock in June?At PG's current levels, I would not buy PG stock. Procter & Gamble stock has many long-term growth catalysts. However, PG is facing shorter-term risks which are likely to push down PG stock price and deflate its valuation.Furthermore, as a result of the recent impressive rise of PG stock over the past year, its short-term technical indicators have become somewhat overextended. Investors who pay attention to short-term oscillators should note that Procter & Gamble stock has become "overbought."So, in the next few weeks, PG stock may be negatively impacted by profit-taking. Investors may want to wait for a better time to buy PG stock, such as when the share price is around $90.Finally, investors who are thinking of buying PG may also want to pay attention to upcoming earnings releases by PG's peers, including Colgate-Palmolive (NYSE:CL), Kimberly Clark (NYSE:KMB), and Clorox (NYSE:CLX). Any weakness in their reports will likely put downward pressure on Procter & Gamble stock.As of this writing, Tezcan Gecgil did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Sell Amid an Escalating Trade War * 5 REITs to Buy While They're Dirt Cheap * The Only 3 Marijuana Stocks You Need to Own Compare Brokers The post Could the Tide Soon Turn for Procter & Gamble Stock? appeared first on InvestorPlace.
OAKLAND, Calif., May 30, 2019 /PRNewswire/ -- A month ago, Operation BBQ Relief set out with community members, and athletes from Achilles International and the Semper Fi Fund to run, bike and hand-cycle across eight communities from Los Angeles to Tampa, Fla, aiming to raise awareness for serving military, first responders and the hungry. Inspired by the effort – and showing faith in the power of BBQ – Kingsford Charcoal has joined the team as a sponsor of the BBQ meal spots along the tour, supplying charcoal for events that will serve more than 10,000 people in each city. This partnership marks the first between Kingsford Charcoal and Operation BBQ Relief.